CSCs were first identified in acute myeloid leukemia (AML) after transplanting isolated CD34+/CD38− cancer cells into non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice. Here, CD34 is linked to acute myeloid leukemia.